Nothing Special   »   [go: up one dir, main page]

IL152224A0 - Stable crystals of thiazolidinedione derivative and process for the preparation thereof - Google Patents

Stable crystals of thiazolidinedione derivative and process for the preparation thereof

Info

Publication number
IL152224A0
IL152224A0 IL15222401A IL15222401A IL152224A0 IL 152224 A0 IL152224 A0 IL 152224A0 IL 15222401 A IL15222401 A IL 15222401A IL 15222401 A IL15222401 A IL 15222401A IL 152224 A0 IL152224 A0 IL 152224A0
Authority
IL
Israel
Prior art keywords
preparation
stable crystals
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
IL15222401A
Other languages
English (en)
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of IL152224A0 publication Critical patent/IL152224A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15222401A 2000-04-25 2001-04-23 Stable crystals of thiazolidinedione derivative and process for the preparation thereof IL152224A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000124006 2000-04-25
PCT/JP2001/003450 WO2001081327A1 (fr) 2000-04-25 2001-04-23 Nouveau cristal stable de derive thiazolidinedione et son procede de production

Publications (1)

Publication Number Publication Date
IL152224A0 true IL152224A0 (en) 2003-05-29

Family

ID=18634205

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15222401A IL152224A0 (en) 2000-04-25 2001-04-23 Stable crystals of thiazolidinedione derivative and process for the preparation thereof

Country Status (23)

Country Link
US (1) US6770133B2 (xx)
EP (1) EP1277745A4 (xx)
KR (1) KR20030007548A (xx)
CN (1) CN1426402A (xx)
AU (1) AU4882801A (xx)
BG (1) BG107200A (xx)
BR (1) BR0110258A (xx)
CA (1) CA2407349A1 (xx)
CZ (1) CZ20023502A3 (xx)
EA (1) EA004244B1 (xx)
EE (1) EE200200601A (xx)
HK (1) HK1053835A1 (xx)
HU (1) HUP0300475A3 (xx)
IL (1) IL152224A0 (xx)
IS (1) IS6586A (xx)
MA (1) MA25664A1 (xx)
MX (1) MXPA02010545A (xx)
NO (1) NO20025069L (xx)
PL (1) PL365533A1 (xx)
SK (1) SK15142002A3 (xx)
WO (1) WO2001081327A1 (xx)
YU (1) YU80302A (xx)
ZA (1) ZA200208293B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1253145B1 (en) * 2000-02-01 2006-09-20 Kyorin Pharmaceutical Co., Ltd. Alkali metal salt of thiazolidine-2,4-dione derivatives
WO2003062214A1 (fr) * 2002-01-23 2003-07-31 Kyorin Pharmaceutical Co., Ltd. Nouveau cristal stable de derive de benzylthiazolidinedione et procede de preparation de celui-ci
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
DE602004004631D1 (de) 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
TWI383008B (zh) * 2005-08-17 2013-01-21 Nippon Catalytic Chem Ind 吸水性樹脂之製造方法及吸水性樹脂以及其利用
TW200838512A (en) 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864028A (en) * 1983-09-14 1989-09-05 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPH04270273A (ja) 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法
JP3053490B2 (ja) 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JP3644998B2 (ja) 1995-02-09 2005-05-11 塩野義製薬株式会社 ベンジリデン誘導体の結晶の選択的取得方法
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
ZA971637B (en) * 1996-02-28 1997-09-25 Nissan Chemical Ind Ltd Thifluzamide with improved efficacy.
JPH101476A (ja) 1996-02-28 1998-01-06 Nissan Chem Ind Ltd 効力が向上したチフルザミド
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
IS6586A (is) 2002-10-21
AU4882801A (en) 2001-11-07
BR0110258A (pt) 2003-01-07
NO20025069D0 (no) 2002-10-22
YU80302A (sh) 2005-11-28
SK15142002A3 (sk) 2003-04-01
EP1277745A1 (en) 2003-01-22
CN1426402A (zh) 2003-06-25
MA25664A1 (fr) 2002-12-31
EE200200601A (et) 2004-04-15
PL365533A1 (en) 2005-01-10
HUP0300475A3 (en) 2004-10-28
US20030101925A1 (en) 2003-06-05
BG107200A (bg) 2003-11-28
HUP0300475A2 (hu) 2003-06-28
NO20025069L (no) 2002-10-22
ZA200208293B (en) 2003-10-06
KR20030007548A (ko) 2003-01-23
EA004244B1 (ru) 2004-02-26
US6770133B2 (en) 2004-08-03
HK1053835A1 (zh) 2003-11-07
EP1277745A4 (en) 2004-09-15
MXPA02010545A (es) 2004-05-14
CA2407349A1 (en) 2002-10-24
WO2001081327A1 (fr) 2001-11-01
CZ20023502A3 (cs) 2003-06-18
EA200201055A1 (ru) 2003-06-26

Similar Documents

Publication Publication Date Title
IL149618A0 (en) Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
EP1405856A4 (en) OLIGOSACCHARIDE CRYSTALS AND METHODS FOR PREPARING THE SAME
HUP0200929A2 (en) Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof
IL152224A0 (en) Stable crystals of thiazolidinedione derivative and process for the preparation thereof
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0200937A3 (en) Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
HUP0100144A3 (en) Process for the preparation of thiazolidinedione derivatives
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
HUP0300804A3 (en) Catalytic process for the preparation of thiazole derivatives
AU8824201A (en) Process for the preparation of dinapsoline
IL153424A0 (en) Process for the preparation of quinoline derivatives
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HUP0202819A3 (en) Process for the preparation of thiazole derivatives and the new intermediates
AU2001248766A1 (en) Process for preparation of sulfonamide derivatives and crystals thereof
IL132524A0 (en) Crystalline form of nefazodone and process for the preparation thereof
AU6875800A (en) Heterocyclic compounds and process for the preparation thereof
AU2001262746A1 (en) Process for the preparation of optically active thiazolidinone derivatives
AU2001274502A1 (en) Process for the preparation of thiazolidinedione derivatives
AU4585000A (en) Process for the preparation of 5-amino-3-alkylisothiazole compounds and of 5-amino-4-chloro-3-alkylisothiazole compounds